Have your own idea? Try our Stock Screener
Belgian (BEL20) Biotech Industry Analysis
UpdatedMar 19, 2026
DataAggregated Company Financials
Companies3
- 7D-5.2%
- 3M-17.6%
- 1Y6.2%
- YTD-17.1%
Over the last 7 days, the Biotech industry has dropped 3.6%, driven by argenx declining 5.2%. On the other hand Celyad Oncology is actually up 5.9%. This takes the industry's 12 month performance to a gain of 9.0%. Earnings are forecast to grow by 22% annually.
Industry Valuation and Performance
Has the Belgian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 19 Mar 2026 | €36.7b | €3.8b | €1.1b | 25.1x | 32.8x | 9.8x |
| Sat, 14 Feb 2026 | €43.4b | €3.2b | €1.3b | 26.5x | 33.8x | 13.8x |
| Mon, 12 Jan 2026 | €42.5b | €3.2b | €1.3b | 24.6x | 32.4x | 13.2x |
| Wed, 10 Dec 2025 | €47.1b | €3.2b | €1.3b | 27x | 35.9x | 14.6x |
| Fri, 07 Nov 2025 | €45.2b | €3.2b | €1.3b | 26x | 34.1x | 13.9x |
| Sun, 05 Oct 2025 | €41.6b | €2.7b | €1.1b | 29x | 38.3x | 15.3x |
| Tue, 02 Sep 2025 | €37.1b | €2.7b | €1.1b | 35.2x | 34.1x | 13.7x |
| Thu, 31 Jul 2025 | €32.1b | €2.4b | €926.1m | 35.4x | 34.6x | 13.6x |
| Sat, 28 Jun 2025 | €29.3b | €2.3b | €903.8m | 34.3x | 32.4x | 12.7x |
| Mon, 26 May 2025 | €31.5b | €2.4b | €931.5m | 33x | 33.8x | 13.2x |
| Wed, 23 Apr 2025 | €32.0b | €2.0b | €723.9m | 43.2x | 44.2x | 15.9x |
| Fri, 21 Mar 2025 | €34.6b | €2.1b | €758.8m | 45x | 45.6x | 16.3x |
| Sun, 16 Feb 2025 | €37.0b | €1.9b | -€47,223,229.00 | n/a | -783x | 19.8x |
| Tue, 14 Jan 2025 | €39.1b | €1.9b | -€48,270,847.00 | n/a | -809.9x | 20.4x |
| Thu, 12 Dec 2024 | €35.1b | €1.9b | -€47,154,730.90 | n/a | -744x | 18.9x |
| Sat, 09 Nov 2024 | €33.2b | €1.8b | -€46,417,369.00 | n/a | -715.4x | 18.2x |
| Mon, 07 Oct 2024 | €28.8b | €1.6b | -€194,639,729.50 | n/a | -147.8x | 18.5x |
| Wed, 04 Sep 2024 | €28.0b | €1.5b | -€194,232,266.50 | n/a | -144x | 18.1x |
| Fri, 02 Aug 2024 | €28.7b | €1.6b | -€198,523,511.50 | n/a | -144.4x | 18.1x |
| Sun, 30 Jun 2024 | €24.3b | €1.4b | -€315,138,696.50 | n/a | -77.2x | 17.4x |
| Tue, 28 May 2024 | €20.4b | €1.4b | -€311,177,681.10 | n/a | -65.6x | 14.8x |
| Thu, 25 Apr 2024 | €20.8b | €1.2b | -€285,023,523.20 | n/a | -73.1x | 17x |
| Sat, 23 Mar 2024 | €22.0b | €1.2b | -€304,539,046.20 | n/a | -72.2x | 18.1x |
| Mon, 19 Feb 2024 | €21.7b | €994.4m | -€249,133,665.70 | n/a | -87.1x | 21.8x |
| Wed, 17 Jan 2024 | €20.8b | €1.0b | -€288,246,151.00 | n/a | -72x | 19.9x |
| Fri, 15 Dec 2023 | €25.3b | €1.0b | -€285,450,198.00 | n/a | -88.5x | 24.5x |
| Sun, 12 Nov 2023 | €27.0b | €1.1b | -€292,907,908.00 | n/a | -92.1x | 25.4x |
| Tue, 10 Oct 2023 | €27.5b | €882.5m | -€452,718,746.00 | n/a | -60.6x | 31.1x |
| Thu, 07 Sep 2023 | €28.4b | €868.4m | -€451,631,510.00 | n/a | -62.8x | 32.7x |
| Sat, 05 Aug 2023 | €26.3b | €835.3m | -€449,210,156.00 | n/a | -58.6x | 31.5x |
| Mon, 03 Jul 2023 | €19.9b | €664.8m | -€558,562,497.00 | n/a | -35.7x | 30x |
| Wed, 31 May 2023 | €20.7b | €676.1m | -€567,726,193.00 | n/a | -36.4x | 30.6x |
| Fri, 28 Apr 2023 | €19.2b | €452.8m | -€724,874,485.00 | n/a | -26.5x | 42.4x |
| Sun, 26 Mar 2023 | €18.7b | €463.3m | -€741,379,158.00 | n/a | -25.3x | 40.5x |
Price to Earnings Ratio
-25.3x
Current Industry PE
- There are only 3 companies in the Belgian Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 100% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare industry?
| BE Market | -1.21% | |
| Healthcare | -2.18% | |
| Biotech | -5.18% | |
| Biotech | -5.18% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CYAD Celyad Oncology | €0.34 | 5.9% +€850.5k | -44.4% | PS81.6x |
